# Hawkins Inc: overview

HWKN · Nasdaq · CIK 46250 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Mar 28

Pages: [Overview](/companies/hwkn.md) · [Financials](/companies/hwkn/financials.md) · [Filings](/companies/hwkn/filings.md) · [Insiders](/companies/hwkn/insiders.md)

Latest reported revenue: [$315.7m](/filings/0000046250-26-000034.md) for Q1 FY2026, three months to 2026-06-28, from the 10-Q filed Jul 29, 2026 (XBRL us-gaap:Revenues, accession 0000046250-26-000034).

## Last eight quarters

| Line item | Unit | Q2 FY2024 (2024-09-29) | Q3 FY2024 (2024-12-29) | Q4 FY2024 (2025-03-30) | Q1 FY2025 (2025-06-29) | Q2 FY2025 (2025-09-28) | Q3 FY2025 (2025-12-28) | Q4 FY2025 (2026-03-29) | Q1 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [247](/filings/0000046250-25-000057.md) | [226](/filings/0000046250-26-000005.md) | [245 d](/filings/0000046250-26-000018.md) | [293](/filings/0000046250-26-000034.md) | [280](/filings/0000046250-25-000057.md) | [244](/filings/0000046250-26-000005.md) | [266 d](/filings/0000046250-26-000018.md) | [316](/filings/0000046250-26-000034.md) |
| Gross margin | % | [24.4%](/filings/0000046250-25-000057.md) | [21.4%](/filings/0000046250-26-000005.md) | [21.3% d](/filings/0000046250-26-000018.md) | [24.7%](/filings/0000046250-26-000034.md) | [24.1%](/filings/0000046250-25-000057.md) | [20.8%](/filings/0000046250-26-000005.md) | [20.4% d](/filings/0000046250-26-000018.md) | [23.4%](/filings/0000046250-26-000034.md) |
| Operating margin | % | [13.7%](/filings/0000046250-25-000057.md) | [9.3%](/filings/0000046250-26-000005.md) | [10.0% d](/filings/0000046250-26-000018.md) | [14.1%](/filings/0000046250-26-000034.md) | [12.1%](/filings/0000046250-25-000057.md) | [9.2%](/filings/0000046250-26-000005.md) | [8.8% d](/filings/0000046250-26-000018.md) | [12.3%](/filings/0000046250-26-000034.md) |
| Net margin | % | [9.8%](/filings/0000046250-26-000005.md) | [6.6%](/filings/0000046250-26-000005.md) | [6.7% d](/filings/0000046250-26-000018.md) | [9.9%](/filings/0000046250-26-000034.md) | [8.1%](/filings/0000046250-26-000005.md) | [5.9%](/filings/0000046250-26-000005.md) | [5.8% d](/filings/0000046250-26-000018.md) | [9.0%](/filings/0000046250-26-000034.md) |
| Diluted EPS | $ per share | [1.16](/filings/0000046250-25-000057.md) | [0.72](/filings/0000046250-26-000005.md) | not reported | [1.40](/filings/0000046250-26-000034.md) | [1.08](/filings/0000046250-25-000057.md) | [0.69](/filings/0000046250-26-000005.md) | not reported | [1.35](/filings/0000046250-26-000034.md) |
| Free cash flow | $m | [31.0 d](/filings/0000046250-25-000057.md) | [12.3 d](/filings/0000046250-26-000005.md) | [19.8 d](/filings/0000046250-26-000018.md) | [17.9](/filings/0000046250-26-000034.md) | [28.7 d](/filings/0000046250-25-000057.md) | [21.2 d](/filings/0000046250-26-000005.md) | [18.2 d](/filings/0000046250-26-000018.md) | [23.5](/filings/0000046250-26-000034.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2022-04-03) | FY2022 (2023-04-02) | FY2023 (2024-03-31) | FY2024 (2025-03-30) | FY2025 (2026-03-29) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [775](/filings/0000046250-24-000013.md) | [935](/filings/0000046250-25-000025.md) | [919](/filings/0000046250-26-000018.md) | [974](/filings/0000046250-26-000018.md) | [1,084](/filings/0000046250-26-000018.md) |
| Gross margin | % | [18.9%](/filings/0000046250-24-000013.md) | [17.7%](/filings/0000046250-25-000025.md) | [21.1%](/filings/0000046250-26-000018.md) | [23.1%](/filings/0000046250-26-000018.md) | [22.6%](/filings/0000046250-26-000018.md) |
| Operating margin | % | [9.2%](/filings/0000046250-24-000013.md) | [9.4%](/filings/0000046250-25-000025.md) | [11.3%](/filings/0000046250-26-000018.md) | [12.2%](/filings/0000046250-26-000018.md) | [11.2%](/filings/0000046250-26-000018.md) |
| Net margin | % | [6.7%](/filings/0000046250-24-000013.md) | [6.4%](/filings/0000046250-25-000025.md) | [8.2%](/filings/0000046250-26-000018.md) | [8.7%](/filings/0000046250-26-000018.md) | [7.5%](/filings/0000046250-26-000018.md) |
| Diluted EPS | $ per share | [2.44](/filings/0000046250-24-000013.md) | [2.86](/filings/0000046250-25-000025.md) | [3.59](/filings/0000046250-26-000018.md) | [4.03](/filings/0000046250-26-000018.md) | [3.91](/filings/0000046250-26-000018.md) |
| Free cash flow | $m | [14.3](/filings/0000046250-24-000013.md) | [29.1](/filings/0000046250-25-000025.md) | [119](/filings/0000046250-26-000018.md) | [70.0](/filings/0000046250-26-000018.md) | [86.1](/filings/0000046250-26-000018.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/hwkn/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $449.1m | 3,160,135 |  | Added +51,634 |
| [KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC](/funds/1021223.md) | 2026-06-30 | $202.9m | 1,428,012 |  | Reduced −98,043 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $150.9m | 1,061,843 |  | Added +18,037 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $121.4m | 854,478 |  | Added +2,836 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $77.8m | 547,510 |  | Added +26,183 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $77.4m | 544,976 |  | Added +20,296 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $73.1m | 514,658 |  | Added +879 |
| [BOWEN HANES & CO INC](/funds/1077583.md) | 2026-06-30 | $58.4m | 380,520 |  | Unchanged |
| [WASATCH ADVISORS LP](/funds/814133.md) | 2026-06-30 | $55.4m | 389,515 |  | Reduced −80,157 |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $40.9m | 287,833 |  | Added +7,852 |

## Recent filings

[All 795 filings](/companies/hwkn/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 16:14 ET | [10-Q](/filings/0000046250-26-000044.md) | Quarterly report, period 2026-09-27 | 0000046250-26-000044 |
| 2026-10-26 | 16:13 ET | [8-K](/filings/0000046250-26-000043.md) | 2.02 Results of operations | 0000046250-26-000043 |
| 2026-08-14 | 16:06 ET | [8-K](/filings/0000046250-26-000039.md) | 5.02 Departure or appointment of officers or directors | 0000046250-26-000039 |
| 2026-08-03 | 16:06 ET | [8-K](/filings/0000046250-26-000037.md) | 5.07 Shareholder vote results | 0000046250-26-000037 |
| 2026-07-29 | 16:15 ET | [10-Q](/filings/0000046250-26-000034.md) | Quarterly report, period 2026-06-28 | 0000046250-26-000034 |
| 2026-07-29 | 16:13 ET | [8-K](/filings/0000046250-26-000033.md) | 2.02 Results of operations | 0000046250-26-000033 |
| 2026-06-18 | 09:16 ET | [DEF 14A](/filings/0000046250-26-000026.md) | Proxy statement, period 2026-03-29 | 0000046250-26-000026 |
| 2026-05-19 | 16:42 ET | [8-K](/filings/0000046250-26-000020.md) | 5.02 Departure or appointment of officers or directors | 0000046250-26-000020 |
| 2026-05-13 | 16:14 ET | [10-K](/filings/0000046250-26-000018.md) | Annual report, period 2026-03-29 | 0000046250-26-000018 |
| 2026-05-13 | 16:13 ET | [8-K](/filings/0000046250-26-000017.md) | 2.02 Results of operations | 0000046250-26-000017 |

## Latest annual report

[Form 10-K for the fiscal year ended Mar 29, 2026](/filings/0000046250-26-000018.md), filed May 13, 2026.

## Forecast league

Q2 FY2026, the quarter ended 2026-09-28, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/e9560d4e-2329-4b27-9c37-db7da56b7e31)

## About the filer

- CIK: 46250
- Tickers: HWKN
- Exchange: Nasdaq
- SIC code: 5160 Wholesale-Chemicals & Allied Products
- State of incorporation: MN
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 11:47 ET. No prices; not investment advice.